Current research has indicated that clinicopathological characteristics such as histological classification, pretreatment carcinoembryonic antigen (CEA) levels, distant metastasis site, and depth of infiltration may also affect survival outcomes in patients with CRC.2 Here, CEACAM5 is linked to colorectal carcinoma.